Get started
180 Life Sciences Corp.180 Life Sciences Corp.180 Life Sciences Corp.

180 Life Sciences Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ATNF chart


Full chart

ATNF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.63 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.81 USD
Net income (FY)
‪−19.94 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪489.94 K‬
Beta (1Y)
0.42

Employees


Employees (FY)
4
Change (1Y)
−1 −20.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−4.98 M‬ USD

About 180 Life Sciences Corp.


Sector
Health Technology
CEO
Blair Jordan
Headquarters
Palo Alto
Website
180lifesciences.com
Founded
2016
FIGI
BBG00H1CP0B4
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ATNF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ATNF is 2.28 USD — it has decreased by −2.56% in the past 24 hours. Watch 180 Life Sciences Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 180 Life Sciences Corp. stocks are traded under the ticker ATNF.
ATNF stock has fallen by −19.15% compared to the previous week, the month change is a −51.90% fall, over the last year 180 Life Sciences Corp. has showed a −68.42% decrease.
ATNF reached its all-time high on Apr 12, 2021 with the price of 4,957.21 USD, and its all-time low was 1.16 USD and was reached on Oct 8, 2024. View more price dynamics on ATNF chart.
See other stocks reaching their highest and lowest prices.
ATNF stock is 10.86% volatile and has beta coefficient of 0.42. Track 180 Life Sciences Corp. stock price on the chart and check out the list of the most volatile stocks — is 180 Life Sciences Corp. there?
Today 180 Life Sciences Corp. has the market capitalization of ‪1.22 M‬, it has decreased by −12.69% over the last week.
Yes, you can track 180 Life Sciences Corp. financials in yearly and quarterly reports right on TradingView.
180 Life Sciences Corp. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ATNF net income for the last quarter is ‪−836.72 K‬ USD, while the quarter before that showed ‪11.78 K‬ USD of net income which accounts for ‪−7.20 K‬% change. Track more 180 Life Sciences Corp. financial stats to get the full picture.
No, ATNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 4.00 employees. See our rating of the largest employees — is 180 Life Sciences Corp. on this list?
Like other stocks, ATNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 180 Life Sciences Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 180 Life Sciences Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 180 Life Sciences Corp. stock shows the sell signal. See more of 180 Life Sciences Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.